Pasithea Therapeutics Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KEPOS CAPITAL LP | 11/13/2025 | 334.60 K | $6.00 K | 0.00% | 5.93% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 50.00 K | $845 | 0.00% | 0.89% |
| MAREX GROUP PLC | 11/14/2025 | 25.00 K | $423 | 0.00% | 0.44% |
| CITADEL ADVISORS LLC | 11/14/2025 | 15.19 K | $207 | -2.06% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 14.59 K | $247 | 100.00% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pasithea Therapeutics Corp. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Pasithea Therapeutics Corp.. The most heavily invested institutionals were:
Kepos Capital LP: 334,600
ARMISTICE CAPITAL, LLC: 50,000
Marex Group plc: 25,000
CITADEL ADVISORS LLC: 15,191
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 14,586
CLEAR STREET LLC: 71
7.79% of Pasithea Therapeutics Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 439.45 K shares in the last 24 months. This purchase volume represents approximately $8.79 K in transactions.